These are known as symptomatic treatments. They include donepezil (part of a family of medicines called cholinesterase inhibitors) and memantine. These are available on the NHS. This type of ...

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, ...

In a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs and U.S. Department of Defen ...

There are four dementia-specific medications approved in Australia – donepezil, galantamine, rivastigmine, and memantine. These available drugs offer symptomatic relief and are neither disease ...

To date, treatment options available to cure AD are limited to one N-methyl-D-aspartate receptor antagonist (Memantine) and ...

When whole-brain radiotherapy (RT) was indicated, hippocampal avoidance and memantine usage were limited to 50.0% and 25.0% of patients, respectively. The most typical RT modality after BM resection ...

Coya Therapeutics is developing treatments for neurodegenerative diseases, with its lead drug COYA 302 showing promising early results in ALS trials. Despite recent delays, the adverse investor ...

Researchers from the University of Massachusetts Chan Medical School studied regional variations in the use of antipsychotic and antidementia medications, such as memantine and cholinesterase ...

Another earlier memantine trial – the Benefit and Efficacy in Severely Demented patients during Treatment with Memantine (M-Best or 9403) study – enrolled participants with moderately severe ...